News & Insight

29 July 2021
News
IMAXT’s Nic Walton: uniting across disciplines to share learnings in data science
data workshop
On the surface, astronomy has little overlap with bioinformatics, mutational analysis and other areas of cancer biology. But, as described by IMAXT’s Nic Walton, an astronomer based at the University of Cambridge, there’s much to learn…

Latest

Video
22 July 2021
Sir Mike Stratton, based at the Wellcome Sanger Institute in Cambridge, UK, leads the Cancer Grand Challenges Mutographs team. Mutographs unites…
News
13 July 2021
Earlier this year, COSMIC - the world's largest and most comprehensive resource for exploring somatic mutations in cancer - celebrated the curation…
Video
30 June 2021
Johanna Joyce is co-investigator of the Cancer Grand Challenges IMAXT team, based in Lausanne, Switzerland.   We caught up with Johanna to learn how…
Video
21 June 2021
Nearly 170 diverse, global teams submitted bold ideas outlining how they would solve some of cancer’s toughest challenges. Today, we reveal the 11…

Latest tweet

Have you watched our latest interview with Professor Sir Mike Stratton @sangerinstitute? He discusses more on how o… https://t.co/CnodEWaGxf Mon Jul 26 10:00:33 +0000 2021

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
Blog
Barbara Rimer is our newest member of the Cancer Grand Challenges Scientific Committee. For International Women’s Day 2021 and as part of our Cancer Grand Challenges Women's Week series, we caught up to discuss the…
8 March 2021
News
Their donation, which rises to £1.25m with Gift Aid, will help scientists uncover secrets of the microbiome, which could lead to new colorectal cancer treatments. “I sold my company back in July, and we’re lucky to…
24 February 2021
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee…
17 February 2021
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee …
3 February 2021
News
In a new Science paper, members of the Cancer Grand Challenges IMAXT team announce ExSeq – new technology that can create nanoscale-resolution genomic maps of tumour samples by combining the expansion of biological…
29 January 2021
Blog
In October, Cancer Grand Challenges posed 9 new quests for the research community, each with the potential to contribute major advances to the way we think about and deal with the burden of cancer. Through our new blog…
25 January 2021
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee …
19 January 2021
Video
In October 2020 we launched 9 new challenges to the global research community, each with the potential to drive radical progress in cancer research. Solving these problems will demand tenacity, creativity and worldwide…
19 January 2021
People
New findings from the Rosetta team have identified the antiporter SLC7A5 as a target for KRAS-driven colorectal cancer. We spoke with some of the co-authors to get their take on how a multidisciplinary team approach…
7 January 2021